CTRI/2015/07/005976尚未招募3 期
A Clinical Trial to Study the Efficacy, Safety and Tolerability of Brinzolamide 10 mg in Combination with Timolol Maleate 5mg Ophthalmic Suspension Vs. Dorzolamide 20mg plus Timolol Maleate 5mg Eye Drops for the Treatment of Patients With Open-Angle Glaucoma or Ocular Hypertension
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 232
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Patient having clinical diagnosis of ocular hypertension.
- •2.Freshly diagnosed patients of open angle glaucoma or ocular hypertension, Patients who are previously diagnosed and on treatment for open angle glaucoma or ocular hypertension will undergo washout period, Meiotic (7 days), Alpha Agonist and Alpha/beta agonist (14 days),β antagonist and prostaglandin analogs (28 days).
- •3.Subject with History of discontinued Carbonic anhydrase inhibitor of 2 months back.
- •4.Availability of subjects for the entire study period and willingness to adhere to protocol requirements as evidenced by written informed consent.
排除标准
- •1.Ocular trauma or intraocular surgery within the past 6 months.
- •2.Ocular infection, inflammation, or laser surgery within the past 3 months.
- •3.Chronic, recurrent or severe inflammatory eye disease
- •4.Central cornea thickness 620 mm, as measured by pachymetry, in either eye
- •5.Shaffer angle grade less than 2 in either eye (range, 0 [complete or partial closure] to 3 [wide open angle, more thab 20]), as measured by Gonioscopy.
- •6.Severe central visual field loss in either eye measured by Perimetry.
- •7.Clinically significant or progressive retinal disease.
- •8.Best-corrected visual acuity worse than 0.6 logMAR (Best Corrected VA score worse than 55 ETDRS letters (20/80 Snellen equivalent))
- •9.Other ocular pathology (including severe dry eye) that may preclude the administration of an alpha-adrenergic agonist and/or a topical CAI.
- •10.A history of hypersensitivity to brinzolamide and other sulphonamides, timolol, or any other component of the medication.
- •11.Patients suffering from bronchial asthma, a history of bronchial asthma, or severe chronic obstructive pulmonary disease.
- •12.Patients suffering from sinus bradycardia, second or third degree atrioventricular block, overt cardiac failure, or cardiogenic shock.
- •13.Patients suffering from severe allergic rhinitis and bronchial hyperreactivity.
- •14.Patients suffering from severe renal impairment (see Hepatic / Renal Impairment).
- •15.Patients who have participated in other clinical studies within 3 months.
- •16.Any condition which are likely to hinder the compliance with the protocol.
- •17.Patients should not take other topical or oral beta-blockers during the study period.
- •18.Patients with broken rear lens capsule or anterior eye lenses or in patients with known risk factors for cystoid macular edema or iritis / uveitis.
- •19.Patients who are scheduled to undergo surgery of the opposite eye during the study period.
- •20.Patients who are required to wear contact lens during the study period.
- •21.Significant visual field loss or evidence of progressive visual field loss within the last year.
- •22.Patients with recent use of high-dose (1 gm daily) salicylate therapy
- •23.Females of childbearing potential if pregnant, lactating, or not using highly effective birth control measures.
- •24.Cup/disc ratio greater than 0.80
- •25.History or current evidence of severe illness or any other conditions which would make the subject, in the opinion of the Investigator, unsuitablefor the study.
- •26.Systemic administration of corticosteroids or immunosuppressive agents and local injection of corticosteroids in the eyes.
研究者
相似试验
已完成
3 期
A Clinical Trial to Study the Efficacy, Safety and Tolerability of Bepotastine Besilate Ophthalmic Solution Vs. Olopatadine Hydrochloride Ophthalmic Solution in Subjects Suffering from Allergic Conjunctivitis.CTRI/2015/01/005399Ajanta Pharma Ltd240
已完成
3 期
A Clinical Study to test the Effectiveness, Safety and Tolerance of Alcaftadine eye drops in comparison with Olopatadine hydrochloride eye drops in patients who are suffering from Allergic ConjunctivitisCTRI/2015/11/006338Ajanta Pharma Ltd204
暂停
3 期
A clinical Trial in patients suffering from open angle glaucoma or ocular hypertension. This clinical trial is to study effect, safety and tolerability of Brinzolamide + Timolol Ophthalmic Suspension (test product) in comparison to Dorzolamide plus Timolol Maleate (reference product)eye drops.CTRI/2012/04/002609Ajanta Pharma Ltd200
尚未招募
3 期
A clinical Trial to study the efficacy, safety and tolerability of Carvedilol Phosphate ER + Amlodipine Capsule Vs Amlodipine + Metoprolol Tablet in Patients with Mild to severe Heart FailureCTRI/2011/09/001989Ajanta Pharma Ltd200
招募中
Unknown
Clinical Trial to Evaluate the Efficacy and Safety of an Algorithm to Determine the Optimal Valve Placement Position during Transcatheter Aortic Valve Implantation Using the Self-Expanding Valve Evolut FXsevere aortic stenosisJPRN-UMIN000051896Shonan Kamakura General Hospital100